Verhoeven RHA - Search Results

1

Phase II Feasibility and Biomarker Study of Neoadjuvant Trastuzumab and Pertuzumab With Chemoradiotherapy for Resectable Human Epidermal Growth Factor Receptor 2-Positive Esophageal Adenocarcinoma: TRAP Study.

Stroes CI, Schokker S, Creemers A, Molenaar RJ, Hulshof MCCM, van der Woude SO, Bennink RJ, Mathôt RAA, Krishnadath KK, Punt CJA, Verhoeven RHA, van Oijen MGH, Creemers GJ, Nieuwenhuijzen GAP, van der Sangen MJC, Beerepoot LV, Heisterkamp J, Los M, Slingerland M, Cats A, Hospers GAP, Bijlsma MF, van Berge Henegouwen MI, Meijer SL, van Laarhoven HWM. Stroes CI, et al. Among authors: verhoeven rha. J Clin Oncol. 2020 Feb 10;38(5):462-471. doi: 10.1200/JCO.19.01814. Epub 2019 Dec 6. J Clin Oncol. 2020. PMID: 31809243 Free PMC article. Clinical Trial.

2

Clinical epidemiology of breast cancer in the elderly.

Louwman WJ, Vulto JC, Verhoeven RH, Nieuwenhuijzen GA, Coebergh JW, Voogd AC. Louwman WJ, et al. Eur J Cancer. 2007 Oct;43(15):2242-52. doi: 10.1016/j.ejca.2007.08.005. Epub 2007 Sep 17. Eur J Cancer. 2007. PMID: 17870517 Review.

3

Effects of age and comorbidity on treatment and survival of patients with muscle-invasive bladder cancer.

Goossens-Laan CA, Leliveld AM, Verhoeven RH, Kil PJ, de Bock GH, Hulshof MC, de Jong IJ, Coebergh JW. Goossens-Laan CA, et al. Int J Cancer. 2014 Aug 15;135(4):905-12. doi: 10.1002/ijc.28716. Epub 2014 Jan 25. Int J Cancer. 2014. PMID: 24420527 Free article.

4

Comparable survival for young rectal cancer patients, despite unfavourable morphology and more advanced-stage disease.

Orsini RG, Verhoeven RH, Lemmens VE, van Steenbergen LN, de Hingh IH, Nieuwenhuijzen GA, Rutten HJ. Orsini RG, et al. Eur J Cancer. 2015 Sep;51(13):1675-82. doi: 10.1016/j.ejca.2015.06.005. Epub 2015 Jul 6. Eur J Cancer. 2015. PMID: 26159248

5

Hospital of diagnosis and probability of having surgical treatment for resectable gastric cancer.

van Putten M, Verhoeven RH, van Sandick JW, Plukker JT, Lemmens VE, Wijnhoven BP, Nieuwenhuijzen GA. van Putten M, et al. Br J Surg. 2016 Feb;103(3):233-41. doi: 10.1002/bjs.10054. Epub 2015 Dec 1. Br J Surg. 2016. PMID: 26621158

6

Perioperative treatment and radical cystectomy for bladder cancer--a population based trend analysis of 10,338 patients in the Netherlands.

Hermans TJN, Fransen van de Putte EE, Horenblas S, Lemmens V, Aben K, van der Heijden MS, Beerepoot LV, Verhoeven RH, van Rhijn BWG. Hermans TJN, et al. Eur J Cancer. 2016 Feb;54:18-26. doi: 10.1016/j.ejca.2015.11.006. Epub 2015 Dec 18. Eur J Cancer. 2016. PMID: 26707593

7

Perioperative Treatment, Not Surgical Approach, Influences Overall Survival in Patients with Gastroesophageal Junction Tumors: A Nationwide, Population-Based Study in The Netherlands.

Koëter M, Parry K, Verhoeven RH, Luyer MD, Ruurda JP, van Hillegersberg R, Lemmens VE, Nieuwenhuijzen GA. Koëter M, et al. Ann Surg Oncol. 2016 May;23(5):1632-8. doi: 10.1245/s10434-015-5061-7. Epub 2016 Jan 4. Ann Surg Oncol. 2016. PMID: 26727917

8

Hospital of Diagnosis Influences the Probability of Receiving Curative Treatment for Esophageal Cancer.

van Putten M, Koëter M, van Laarhoven HWM, Lemmens VEPP, Siersema PD, Hulshof MCCM, Verhoeven RHA, Nieuwenhuijzen GAP. van Putten M, et al. Among authors: verhoeven rha. Ann Surg. 2018 Feb;267(2):303-310. doi: 10.1097/SLA.0000000000002063. Ann Surg. 2018. PMID: 27811508

9

Pathological downstaging and survival after induction chemotherapy and radical cystectomy for clinically node-positive bladder cancer-Results of a nationwide population-based study.

Hermans TJ, Fransen van de Putte EE, Horenblas S, Meijer RP, Boormans JL, Aben KK, van der Heijden MS, de Wit R, Beerepoot LV, Verhoeven RH, van Rhijn BW. Hermans TJ, et al. Eur J Cancer. 2016 Dec;69:1-8. doi: 10.1016/j.ejca.2016.09.015. Epub 2016 Oct 27. Eur J Cancer. 2016. PMID: 27814469

10

Regional and inter-hospital differences in the utilisation of liver surgery for patients with synchronous colorectal liver metastases in the Netherlands.

't Lam-Boer J, van der Stok EP, Huiskens J, Verhoeven RH, Punt CJ, Elferink MA, de Wilt JH, Verhoef C; CAIRO5/CHARISMA Group. 't Lam-Boer J, et al. Eur J Cancer. 2017 Jan;71:109-116. doi: 10.1016/j.ejca.2016.10.026. Epub 2016 Dec 16. Eur J Cancer. 2017. PMID: 27988444

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

184 results

Search Page